About this Event
Program Overview
Cytomegalovirus (CMV) remains one of the most common and clinically significant infectious complications following solid organ and allogeneic hematopoietic stem cell transplantation. As recent advances have expanded the therapeutic landscape with newer antiviral agents for CMV prophylaxis and treatment, guideline recommendations have continued to evolve to support optimal CMV prevention, monitoring, and management. Keeping pace with indication expansions, updated guidelines, and emerging clinical data can be challenging, requiring clinicians to reassess how best to integrate evolving evidence into practice across diverse transplant populations. Through case-based discussion, join expert faculty as they examine the evolving roles of newer antiviral therapies, including letermovir and maribavir; review the latest guideline recommendations and emerging clinical data; and discuss their application to real-world transplant scenarios to optimize patient care.
Target Audience
This educational initiative is intended for transplant surgeons, cardiothoracic surgeons/clinicians, infectious disease clinicians, critical care clinicians, hospitalists, nurses, pharmacists, and other HCPs involved in the care of solid organ transplant recipients.
Educational Objectives
Upon completion of this activity, learners should be better able to:
Evaluate the clinical data supporting the efficacy and safety of new CMV antivirals across patient populations and post-transplant settings
Identify key updates in guideline consensus recommendations for CMV management in solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients
Develop evidence-based preventative and treatment plans using modern CMV antivirals
Assess potential drug-drug interactions with new CMV antivirals to minimize the risk of serious toxicities and adverse effects
Commercial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
This program is in partnership with AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.
Joint Accreditation Statement
Credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph*rm*cy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Types Offered
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Credit being awarded: 1.0 ANCC contact hours.
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.0 contact hours.
Criteria for Success
Certificates of completion will be awarded based on the participant’s attendance and submission of the activity evaluation/claim credit form. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at [email protected].
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the U.S. Food and Drug Administration (FDA). Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional and, therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants’ misunderstanding of the content. If you would like to opt out from future communications from AKH Inc., please send an email to [email protected] with your information with “Opt Out” in the subject line.
Event venue & nearby stays
Marriott Marquis Washington, DC, 901 Massachusetts Avenue Northwest, Washington, United States
Concerts, fests, parties, meetups — all the happenings, one place.